Wiegand J - Search Results

1

Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).

Wiegand J, Buggisch P, Mauss S, Boeker KHW, Klinker H, Müller T, Günther R, Serfert Y, Manns MP, Zeuzem S, Berg T, Hinrichsen H, C-Registry GH. Wiegand J, et al. Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1424-1431. doi: 10.1097/MEG.0000000000001426. Eur J Gastroenterol Hepatol. 2019. PMID: 31589184

2

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: wiegand j. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

3

[Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3].

Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP. Cornberg M, et al. Among authors: wiegand j. Z Gastroenterol. 2003 Jun;41(6):517-22. doi: 10.1055/s-2003-39649. Z Gastroenterol. 2003. PMID: 12806536 German.

4

Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.

Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C, Tillmann HL. Wiegand J, et al. Z Gastroenterol. 2004 Jan;42(1):15-8. doi: 10.1055/s-2004-812683. Z Gastroenterol. 2004. PMID: 14997399

5

Acute hepatitis C virus infection: to treat or not to treat?

Jaeckel E, Wedemeyer H, Wiegand J, Manns MP. Jaeckel E, et al. Among authors: wiegand j. Gastroenterology. 2004 Apr;126(4):1219-20; author reply 1220. doi: 10.1053/j.gastro.2004.02.041. Gastroenterology. 2004. PMID: 15057772 No abstract available.

6

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.

Wedemeyer H, Jäckel E, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: wiegand j. Hepatology. 2004 May;39(5):1201-3. doi: 10.1002/hep.20221. Hepatology. 2004. PMID: 15122747 Review. No abstract available.

7

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.

Pradat P, Maynard M, Buti M, Berthillon P, Picchio G, Tillmann HL, Wiegand J, Voirin N, Manns MP, Esteban JI, Martinot M, Marcellin P, Trepo C. Pradat P, et al. Among authors: wiegand j. J Med Virol. 2004 Jul;73(3):392-6. doi: 10.1002/jmv.20104. J Med Virol. 2004. PMID: 15170634

8

Long-term follow-up after successful interferon therapy of acute hepatitis C.

Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Wiegand J, et al. Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091

9

Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.

Tillmann HL, Wiegand J, Glomb I, Jelineck A, Picchio G, Wedemeyer H, Manns MP. Tillmann HL, et al. Among authors: wiegand j. Z Gastroenterol. 2005 Jan;43(1):11-6. doi: 10.1055/s-2004-813429. Z Gastroenterol. 2005. PMID: 15650966

10

Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse.

Potthoff A, Sarhaddar J, Wiegand J, Lichtinghagen R, Sarrazin C, Ciner A, Hadem J, Trautwein C, Manns MP, Wedemeyer H. Potthoff A, et al. Among authors: wiegand j. Hepatol Res. 2005 Jan;31(1):18-23. doi: 10.1016/j.hepres.2004.11.007. Epub 2005 Jan 8. Hepatol Res. 2005. PMID: 15652466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page